Total Payments
$94,734
2024 Payments
$8,674
Companies
6
Transactions
113
Medicare Patients
1,092
Medicare Billing
$99,362
Payment Breakdown by Category
Consulting$45,656 (48.2%)
Other$42,022 (44.4%)
Travel$5,178 (5.5%)
Food & Beverage$1,879 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $45,656 | 26 | 48.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,022 | 22 | 44.4% |
| Travel and Lodging | $5,178 | 39 | 5.5% |
| Food and Beverage | $1,879 | 26 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI PASTEUR INC. | $57,778 | 75 | $0 (2023) |
| PFIZER INC. | $22,355 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $6,731 | 8 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $6,727 | 11 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,033 | 1 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $111.08 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,674 | 7 | PFIZER INC. ($8,674) |
| 2023 | $14,724 | 14 | SANOFI PASTEUR INC. ($9,518) |
| 2022 | $9,737 | 8 | SANOFI PASTEUR INC. ($5,362) |
| 2021 | $6,108 | 3 | PFIZER INC. ($5,100) |
| 2020 | $15,887 | 16 | SANOFI PASTEUR INC. ($11,445) |
| 2019 | $16,318 | 31 | SANOFI PASTEUR INC. ($13,886) |
| 2018 | $19,747 | 27 | Sanofi Pasteur Inc. ($16,059) |
| 2017 | $3,539 | 7 | SANOFI-AVENTIS U.S. LLC ($3,039) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | PFIZER INC. | ABRYSVO (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: VACCINES | ||||||
| 05/02/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| 04/26/2024 | PFIZER INC. | ABRYSVO (Biological) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: VACCINES | ||||||
| 03/08/2024 | PFIZER INC. | ABRYSVO (Biological) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: VACCINES | ||||||
| 02/02/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $339.48 | General |
| Category: VACCINES | ||||||
| 02/02/2024 | PFIZER INC. | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $184.84 | General |
| Category: VACCINES | ||||||
| 01/08/2024 | PFIZER INC. | ABRYSVO (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: VACCINES | ||||||
| 12/19/2023 | PFIZER INC. | ABRYSVO (Biological) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: VACCINES | ||||||
| 10/24/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: VACCINES | ||||||
| 09/21/2023 | SANOFI PASTEUR INC. | MENQUADFI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Vaccines | ||||||
| 08/22/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: VACCINES | ||||||
| 07/21/2023 | PFIZER INC. | EUCRISA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,400.00 | General |
| Category: DERMATOLOGY | ||||||
| 06/23/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| 03/29/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,020.00 | General |
| Category: Vaccines | ||||||
| 03/29/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Travel and Lodging | Cash or cash equivalent | $339.88 | General |
| Category: Vaccines | ||||||
| 03/29/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Travel and Lodging | Cash or cash equivalent | $299.80 | General |
| Category: Vaccines | ||||||
| 03/29/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Travel and Lodging | Cash or cash equivalent | $120.75 | General |
| Category: Vaccines | ||||||
| 03/29/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Food and Beverage | Cash or cash equivalent | $62.41 | General |
| Category: Vaccines | ||||||
| 03/29/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: Vaccines | ||||||
| 03/29/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Travel and Lodging | Cash or cash equivalent | $44.54 | General |
| Category: Vaccines | ||||||
| 02/14/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/17/2022 | SANOFI PASTEUR INC. | MENQUADFI (Biological) | Consulting Fee | Cash or cash equivalent | $1,243.00 | General |
| Category: Vaccines | ||||||
| 11/03/2022 | SANOFI PASTEUR INC. | MENQUADFI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,243.00 | General |
| Category: Vaccines | ||||||
| 08/26/2022 | SANOFI PASTEUR INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,278.00 | General |
| 08/25/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 271 | 390 | $84,770 | $26,105 |
| 2022 | 7 | 216 | 283 | $50,395 | $16,333 |
| 2021 | 8 | 227 | 309 | $47,071 | $21,525 |
| 2020 | 11 | 378 | 523 | $77,382 | $35,400 |
Total Patients
1,092
Total Services
1,505
Medicare Billing
$99,362
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 92 | $11,960 | $5,834 | 48.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 107 | $29,425 | $5,605 | 19.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $9,240 | $3,951 | 42.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 31 | $7,595 | $2,899 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 51 | $9,690 | $2,428 | 25.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $6,720 | $1,375 | 20.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 19 | $2,470 | $1,256 | 50.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $4,455 | $970.80 | 21.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $1,620 | $856.38 | 52.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $825.00 | $480.75 | 58.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $770.00 | $448.70 | 58.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 79 | $19,005 | $4,530 | 23.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 60 | $7,800 | $3,495 | 44.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 50 | $8,350 | $2,361 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $7,560 | $2,137 | 28.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $3,240 | $1,645 | 50.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,900 | $1,286 | 44.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $1,540 | $879.48 | 57.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 89 | $17,355 | $6,554 | 37.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 26 | 26 | $5,096 | $3,731 | 73.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 58 | $7,600 | $3,541 | 46.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 59 | $8,260 | $3,157 | 38.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $3,360 | $1,624 | 48.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 21 | 21 | $2,100 | $1,370 | 65.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 17 | 18 | $2,628 | $1,110 | 42.3% |
About John Russell
John Russell is a Family Medicine healthcare provider based in Jenkintown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336171206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Russell has received a total of $94,734 in payments from pharmaceutical and medical device companies, with $8,674 received in 2024. These payments were reported across 113 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($45,656).
As a Medicare-enrolled provider, Russell has provided services to 1,092 Medicare beneficiaries, totaling 1,505 services with total Medicare billing of $99,362. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Jenkintown, PA
- Active Since 07/07/2006
- Last Updated 07/14/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336171206
Products in Payments
- FLUZONE HIGH-DOSE (Drug) $16,709
- ABRYSVO (Biological) $9,024
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $8,619
- EUCRISA (Drug) $7,900
- SOLIQUA (Drug) $6,727
- FLUZONE QUADRIVALENT (Biological) $6,311
- FLUZONE HIGH-DOSE (Biological) $6,101
- FLUBLOK QUADRIVALENT (Drug) $5,266
- MENACYW CONJUGATE VACCINE (Drug) $4,816
- MENQUADFI (Biological) $4,061
- NO PRODUCT DISCUSSED (Drug) $3,654
- PREVNAR 20 (Biological) $2,981
- TRELEGY ELLIPTA (Drug) $2,555
- NUCALA (Biological) $2,190
- Non-Covered $1,033
- ADACEL (Biological) $963.00
- ANORO ELLIPTA (Drug) $730.00
- BEXSERO (Biological) $124.76
- GARDASIL (Biological) $111.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jenkintown
Neil Skolnik, M.d, M.D
Family Medicine — Payments: $1.0M
Family Medicine $1.0M
Dr. Christopher Notte, M.d, M.D
Family Medicine — Payments: $19,909
Family Medicine $19,909
Amy Clouse, M.d, M.D
Family Medicine — Payments: $7,059
Family Medicine $7,059
Marc Kress, M.d, M.D
Family Medicine — Payments: $5,385
Family Medicine $5,385
Dr. Christina Chovanes, M.d, M.D
Family Medicine — Payments: $3,976
Family Medicine $3,976
Dr. Meera Shah, D.o, D.O
Family Medicine — Payments: $1,130
Family Medicine $1,130